Valley National Bancorp Non-Cum Perp Red Pfd Registered Shs Series B Earnings Calls
| Release date | Apr 23, 2026 |
| EPS estimate | $0.274 |
| EPS actual | $0.290 |
| EPS Surprise | 5.84% |
| Revenue estimate | 533.029M |
| Revenue actual | 540.361M |
| Revenue Surprise | 1.38% |
| Release date | Jan 29, 2026 |
| EPS estimate | $0.289 |
| EPS actual | $0.310 |
| EPS Surprise | 7.30% |
| Revenue estimate | 525.795M |
| Revenue actual | 541.248M |
| Revenue Surprise | 2.94% |
| Release date | Oct 22, 2025 |
| EPS estimate | $0.258 |
| EPS actual | $0.290 |
| EPS Surprise | 12.41% |
| Revenue estimate | 510.908M |
| Revenue actual | 891.81M |
| Revenue Surprise | 74.55% |
| Release date | Jul 23, 2025 |
| EPS estimate | $0.216 |
| EPS actual | $0.237 |
| EPS Surprise | 9.43% |
| Revenue estimate | 525.035M |
| Revenue actual | 867.612M |
| Revenue Surprise | 65.25% |
Last 4 Quarters for Valley National Bancorp Non-Cum Perp Red Pfd Registered Shs Series B
Below you can see how VLYPO performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 23, 2025 |
| Price on release | $25.15 |
| EPS estimate | $0.216 |
| EPS actual | $0.237 |
| EPS surprise | 9.43% |
| Date | Price |
|---|---|
| Jul 17, 2025 | $24.80 |
| Jul 18, 2025 | $24.92 |
| Jul 21, 2025 | $25.00 |
| Jul 22, 2025 | $25.03 |
| Jul 23, 2025 | $25.15 |
| Jul 24, 2025 | $25.10 |
| Jul 25, 2025 | $24.99 |
| Jul 28, 2025 | $25.05 |
| Jul 29, 2025 | $25.09 |
| 4 days before | 1.41% |
| 4 days after | -0.239% |
| On release day | -0.199% |
| Change in period | 1.17% |
| Release date | Oct 22, 2025 |
| Price on release | $25.16 |
| EPS estimate | $0.258 |
| EPS actual | $0.290 |
| EPS surprise | 12.41% |
| Date | Price |
|---|---|
| Oct 16, 2025 | $24.86 |
| Oct 17, 2025 | $25.00 |
| Oct 20, 2025 | $25.04 |
| Oct 21, 2025 | $25.24 |
| Oct 22, 2025 | $25.16 |
| Oct 23, 2025 | $24.99 |
| Oct 24, 2025 | $25.14 |
| Oct 27, 2025 | $25.15 |
| Oct 28, 2025 | $25.09 |
| 4 days before | 1.21% |
| 4 days after | -0.278% |
| On release day | -0.672% |
| Change in period | 0.93% |
| Release date | Jan 29, 2026 |
| Price on release | $25.05 |
| EPS estimate | $0.289 |
| EPS actual | $0.310 |
| EPS surprise | 7.30% |
| Date | Price |
|---|---|
| Jan 23, 2026 | $25.05 |
| Jan 26, 2026 | $25.10 |
| Jan 27, 2026 | $25.07 |
| Jan 28, 2026 | $25.07 |
| Jan 29, 2026 | $25.05 |
| Jan 30, 2026 | $25.17 |
| Feb 02, 2026 | $25.11 |
| Feb 03, 2026 | $25.09 |
| Feb 04, 2026 | $25.18 |
| 4 days before | 0% |
| 4 days after | 0.507% |
| On release day | 0.479% |
| Change in period | 0.507% |
| Release date | Apr 23, 2026 |
| Price on release | $24.97 |
| EPS estimate | $0.274 |
| EPS actual | $0.290 |
| EPS surprise | 5.84% |
| Date | Price |
|---|---|
| Apr 17, 2026 | $24.90 |
| Apr 20, 2026 | $24.90 |
| Apr 21, 2026 | $24.86 |
| Apr 22, 2026 | $24.90 |
| Apr 23, 2026 | $24.97 |
| Apr 24, 2026 | $25.00 |
| Apr 27, 2026 | $25.00 |
| Apr 28, 2026 | $25.00 |
| Apr 29, 2026 | $25.01 |
| 4 days before | 0.281% |
| 4 days after | 0.145% |
| On release day | 0.120% |
| Change in period | 0.426% |
Valley National Bancorp Non-Cum Perp Red Pfd Registered Shs Series B Earnings Call Transcript Summary of Q1 2026
Valley National Bancorp reported solid Q1 2026 results with net income of ~$164 million ($0.28 diluted EPS) and adjusted net income of $169 million ($0.29). Adjusted pre-provision net revenue rose to $253 million. Management signaled upside to prior NII guidance—expecting annual net interest income growth toward the higher end of prior guidance and acceleration in H2—driven by strong core deposit gathering (direct customer deposits +$900 million in the quarter), loan growth (total loans +$700 million; C&I and owner-occupied CRE strength, especially in health care), and a favorable yield curve. Deposit costs declined ~18 bps; loans-to-non-brokered-deposits improved to 106% from 112% a year ago. Management repaid nearly $300M brokered deposits and $350M FHLB advances, de-risking funding. Total deposits are expected to grow toward the high end of the 5–7% guide. Loan growth is expected between mid and high end of prior 4–6% guidance, with a robust C&I pipeline and continued healthcare vertical strength. Efficiency improved (adjusted efficiency ratio 53.1% vs. 55.9% a year ago) and management reiterated a goal of trending toward a ~50% efficiency ratio by 2026. Capital generation funded >30 bps of regulatory capital; roughly one-third of capital generation was used for buybacks this quarter (~$52M); management expects buyback activity to remain but likely somewhat lower near-term to support loan growth and maintain CET1 toward the high end of its 10.5–11% target range. Asset quality remains stable: net charge-offs improved to 14 bps, allowance coverage ~1.2%, criticized/classified loans expected to continue declining. Management highlighted continued investments in AI and data infrastructure that are already being applied to underwriting, fraud detection, collections, and sales productivity to improve efficiency and client experience.
Sign In
Buy VLYPO